Inflammatory Bowel Disease

1385 WordsJul 16, 20186 Pages
Inflammatory Bowel Disease 1. Describe the pathopysiology of the disease you have chosen – What is the spectrum of disease/pathology the disease? Is the disease characterized by inflammation, etc? Is it an infectious and/or chronic disease? If so what is the agent, its reservoir, mode of transmission etc. Inflammatory bowel disease is a chronic illness characterized by inflammation in the gastrointestinal tract (Wolf, CDC, Mayo clinic, health direct, NHS choices). Patients suffering from inflammatory bowel disease usually face with severe chronic pain in their stomach, diarrhea, which may contain blood, loss of appetite, joint pains, skin problems, fever, fatigue, etc. Symptoms can appear for periods of time and can appear in different…show more content…
Though anyone at any age can develop inflammatory bowel disease, the people between the ages of fifteen and thirty are more likely to get diagnosed with the disease, with about 10% of cases occurring to individuals younger than eighteen (CDC). People who are direct descendents of those with inflammatory bowel disease and other gastrointestinal problems are more likely to develop the disease themselves (CDC, Wolf, Mayo clinic). Though anyone can develop the disease, inflammatory bowel disease is most common in those with a European and Jewish descent, who are Caucasian, and those who are White (CDC, Wolf, Mayo clinic). Females are more likely to develop Crohn’s, while males are more likely to develop Crohn’s (CDC). Inflammatory bowel disease is more common in developed countries, with a greater frequency in urban areas than in rural areas, indicating globalization to be a contributing factor for inflammatory bowel disease (CDC, Ghosh and Almadi). Australia seems to have one of the highest incidence rates of the disease in the world with about 33,000 having colitis and 28,000 (health direct). Inflammatory bowel disease is also one of the most prevalent gastrointestinal disease in the United States with the prevalence of the disease being greater than 200 cases per 100,000 and a total of about one million to 1.5 million people having the disease currently (CDC, Wolf, Rubin et al). 4. What is the analytic epidemiology of the
Open Document